{"id":"https://openalex.org/keywords/cyp2c19-2-polymorphism","display_name":"CYP2C19*2 polymorphism","description":"The CYP2C19*2 polymorphism is a genetic variant associated with reduced CYP2C19 enzyme activity and altered responses to medications.","display_name_alternatives":["CYP2C19 star 2 polymorphism","CYP2C19 rs4244285 polymorphism","CYP2C19 681G>A polymorphism","CYP2C19 G681A polymorphism"],"ids":{"openalex":"https://openalex.org/keywords/cyp2c19-2-polymorphism","wikidata":null},"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.7369,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.7369,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2198,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"works_count":107,"cited_by_count":2175,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/cyp2c19-2-polymorphism","updated_date":"2026-11-19T04:05:57","created_date":"2026-09-30T00:00:00"}
